Altimmune Announces Second Quarter 2022 Financial Results and Provides a Business Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/12/2026
- S&P 500 ends higher as strong inflation data cements rate-hike bets
- Oracle raises full year profit guidance, stock rises after hours
- Oil falls but head for 8% weekly gain on tight supply; US diesel hits record
- 'No panic anywhere' may be the problem, BofA strategists warn
- Buy Shopify stock at this ’AI-enabled entry point,’ analyst says
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
Altimmune, Inc. (ALT) Tops Q2 EPS by 8c
August 11, 2022 7:04 AM EDTAltimmune, Inc. (NASDAQ: ALT) reported Q2 EPS of ($0.42), $0.08 better than the analyst estimate of ($0.50). Revenue for the quarter came in at $8 thousand versus the consensus estimate of $866.67 thousand.
For earnings history and earnings-related data on Altimmune, Inc. (ALT) click here.
... More